$96B
US chronic pain management market in 2026
Source: IBISWorld Pain Management Report 2026
Who We Serve
Pain Management Doctors
Interventional pain physicians reduce opioid and steroid reliance with biologics, shockwave, and neuromodulatory peptide protocols.
Pain management doctors — anesthesiology, PM&R, and interventional pain — treat chronic axial and peripheral pain, radiculopathy, facet arthropathy, SI joint dysfunction, and peripheral neuropathy. Regenerative options (PRP, exosomes, MSCs, ECSWT) and peptide adjuncts (BPC-157, LL-37, thymosin peptides) let you offer durable, non-opioid alternatives when repeat steroid injections and long-term opioids aren't the answer.
By the numbers
2026 stats you should know
38%
Pain practices offering regenerative injections in 2026 (up from 19% in 2022)
Source: ASIPP 2026 Practice Survey
42%
Median reduction in opioid MED after 6 months of combined biologic + PBM protocols
Source: Pain Physician Journal 2026 case series
2.1×
Increase in cash-pay procedural revenue after adding PRP/exosome injections
Source: ASIPP 2026 Financial Benchmarks
Benefits
Non-opioid, non-steroid options
Biologics and shockwave give you durable interventions that don't compound cartilage loss or opioid dependence.
Address the tissue, not just the signal
PRP and exosomes target degenerative discs, facet capsules, and peripheral tendons — modifying the source of pain rather than blocking it.
Reduced steroid load per patient
Alternating regenerative injections with fluoroscopic steroids extends symptom control while lowering cumulative steroid exposure.
Cash-pay procedure line
Regenerative procedures create a cash-pay line alongside insurance-billed interventional work.
How they help patients
- Facet arthropathy and SI joint pain
- Cervical and lumbar discogenic pain
- Chronic tendinopathies and myofascial pain
- Post-surgical spine and knee pain
- Peripheral neuropathy adjunctive support (LLLT/PBM)
- Opioid-tapering support with peptide and PBM protocols
Tools & Services Pain Practices Use
Fluoroscopy- and ultrasound-guided biologic injections, shockwave, laser, and peptide adjuncts — supplied by one partner.
Biologics
PRP, exosomes, MSCs, and amniotic allografts for spine, joints, and peripheral tendons.
Devices
ECSWT for chronic tendinopathies, HPLT for deep tissue, LLLT/PBM for neuropathic pain and recovery.
Peptide adjuncts
BPC-157, thymosin peptides, and LL-37 protocols for inflammation and tissue repair.
Supplies & PPE
Injection kits, sterile consumables, and PPE for high-volume interventional suites.
How we onboard your practice
- Step 1Diagnostic alignment
We help match imaging, exam, and diagnostic blocks to the right regenerative intervention.
- Step 2Procedure setup
Fluoro/US kits, biologics sourcing, and device integration in your existing suite.
- Step 3Outcome tracking
VAS, ODI, and opioid MED tracking to demonstrate value to patients and payers.
Frequently asked questions
How do biologics fit alongside epidural steroid injections?
Many pain physicians alternate ESIs with intradiscal or facet PRP/exosome injections to extend relief and reduce cumulative steroid exposure. We help design combined protocols.
Can peptides really reduce opioid needs?
BPC-157 and thymosin peptides address underlying inflammation and tissue repair; combined with PBM and biologics, many patients require lower opioid MED over 3–6 months. Evidence is emerging — we share the current literature.
Add regenerative options to your pain practice
We'll help you build a non-opioid pathway with biologics, ECSWT/HPLT/LLLT, and peptide adjuncts.